当前位置：首页 > 文献互助 > 互助详情

An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice复制

用户KOvIbdV3eQTk 1小时前 12 30 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-02-10 13:41:46 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1126/scitranslmed.adw9446复制

文献链接: https://www.science.org/doi/10.1126/scitranslmed.adw9446复制

其他信息:

出版社: American Association for the Advancement of Science (AAAS)
作者: Ankit Uniyal; Niyada Hin; Chi Zhang; Qian Xu; Qian Huang; Ilyas Berhane; Ajit G. Thomas; John Maragakis; Sadakatali Gori; Jing Liu; Qin Zheng; Xiang Cui; Qi Peng; Jieru Wan; Rana Rais; Barbara S. Slusher; Srinivasa. N. Raja; Xinzhong Dong; Takashi Tsukamoto; Yun Guan

上一篇：Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study

下一篇：Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

互助时间线

2026-02-03 13:42:26 [完结求助]

楼主确认了笑出声来3应助的文件是正确的, 求助状态变成 已完结

2026-02-03 13:41:46 [上传文件]

笑出声来3上传了文件(pdf 3.09 MB), 求助状态变成 待确认

2026-02-03 13:41:43 [发起求助]

最新发布的求助

FDA approved PFS-based autoinjectors: evolution, market trends, and development challenges 2分钟前
Do institutional factors influence the opportunities for social organizations to participate in community governance? An empirical study based on Guangdong, Hunan and Qinghai provinces 18分钟前
…治疗性药物组合RYZ811（诊断用）和RYZ801（治疗用）用于曾治疗过不可切除肝细胞癌的草甘-3阳性（GPC3 ）患者...... 22分钟前
阿罗洛尔治疗原发性高血压的优势与来自东亚的证据 33分钟前
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy 1小时前
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice 1小时前
Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study 1小时前
Equity Incentives and Corporate Innovation: A Case Study of Joyoung Co., Ltd. 1小时前
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) 2小时前
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today? 2小时前
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements 3小时前
Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com